Cargando…
The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis
BACKGROUND: Until now, there is no effective anti-fibrotic therapy available for liver cirrhosis. Stem cell therapies have been studied for the treatment of hepatic fibrosis. However, the use of embryonic stem cells or induced pluripotent stem cells (iPSC) has limitations such as ethical concern or...
Autores principales: | Park, Suhyun, In Hwang, Seon, Kim, Jonghun, Hwang, Seoyeon, Kang, Sohee, Yang, Sera, Kim, Jonghwa, Kang, Wonseok, Kim, Kyun-Hwan, Han, Dong Wook, Paik, Yong-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330392/ https://www.ncbi.nlm.nih.gov/pubmed/30635054 http://dx.doi.org/10.1186/s13287-018-1127-3 |
Ejemplares similares
-
Metastable Reprogramming State of Single Transcription Factor-Derived Induced Hepatocyte-Like Cells
por: Hwang, Seon In, et al.
Publicado: (2019) -
Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis
por: Kim, Jonghwa, et al.
Publicado: (2020) -
Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts
por: Kim, Jonghun, et al.
Publicado: (2015) -
Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
por: Kim, Yohan, et al.
Publicado: (2017) -
Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis
por: Hwang, Injoo, et al.
Publicado: (2021)